AAP Recommends Influenza Vaccines for Children 6 Months and Older

In a move aimed at mitigating the spread of influenza among children, the American Academy of Pediatrics Committee on Infectious Diseases has issued updated recommendations for the use of influenza vaccines and antiviral medications during the upcoming 2026-2027 influenza season. According to the committee's guidelines, the updated recommendations reflect the latest scientific evidence and aim to provide healthcare professionals with the most effective strategies for preventing and treating influenza in children.

Key changes to the recommendations include the endorsement of annual influenza vaccination for all children aged six months and older, with a particular emphasis on high-risk populations such as those with certain chronic health conditions and young children. The committee also recommends the use of antiviral medications, such as oseltamivir and zanamivir, for the treatment and prevention of influenza in children, particularly in cases where vaccination is not feasible or has been administered too recently to provide adequate protection. Additionally, the guidelines emphasize the importance of prompt antiviral treatment initiation within 48 hours of symptom onset to maximize the effectiveness of these medications.

The updated recommendations from the American Academy of Pediatrics Committee on Infectious Diseases aim to help healthcare professionals provide the best possible care for children during the 2026-2027 influenza season. By following these guidelines, healthcare providers can help reduce the spread of influenza and minimize the risk of severe illness and complications in vulnerable populations.